BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 33544339)

  • 1. MicroRNA signature in classical Hodgkin lymphoma.
    Paczkowska J; Giefing M
    J Appl Genet; 2021 May; 62(2):281-288. PubMed ID: 33544339
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of miRNA profiles of microdissected Hodgkin/Reed-Sternberg cells and Hodgkin cell lines versus CD77+ B-cells reveals a distinct subset of differentially expressed miRNAs.
    Van Vlierberghe P; De Weer A; Mestdagh P; Feys T; De Preter K; De Paepe P; Lambein K; Vandesompele J; Van Roy N; Verhasselt B; Poppe B; Speleman F
    Br J Haematol; 2009 Dec; 147(5):686-90. PubMed ID: 19775296
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Tumor Suppressive mir-148a Is Epigenetically Inactivated in Classical Hodgkin Lymphoma.
    Paczkowska J; Janiszewska J; Bein J; Schneider M; Bednarek K; Ustaszewski A; Hartmann S; Hansmann ML; Giefing M
    Cells; 2020 Oct; 9(10):. PubMed ID: 33066457
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analyzing primary Hodgkin and Reed-Sternberg cells to capture the molecular and cellular pathogenesis of classical Hodgkin lymphoma.
    Tiacci E; Döring C; Brune V; van Noesel CJ; Klapper W; Mechtersheimer G; Falini B; Küppers R; Hansmann ML
    Blood; 2012 Nov; 120(23):4609-20. PubMed ID: 22955914
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA signatures and treatment response in patients with advanced classical Hodgkin lymphoma.
    Sánchez-Espiridión B; Martín-Moreno AM; Montalbán C; Figueroa V; Vega F; Younes A; Medeiros LJ; Alvés FJ; Canales M; Estévez M; Menarguez J; Sabín P; Ruiz-Marcellán MC; Lopez A; Sánchez-Godoy P; Burgos F; Santonja C; López JL; Piris MA; Garcia JF
    Br J Haematol; 2013 Aug; 162(3):336-47. PubMed ID: 23725219
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hodgkin-Reed-Sternberg cells in classical Hodgkin lymphoma show alterations of genes encoding the NADPH oxidase complex and impaired reactive oxygen species synthesis capacity.
    Giefing M; Winoto-Morbach S; Sosna J; Döring C; Klapper W; Küppers R; Böttcher S; Adam D; Siebert R; Schütze S
    PLoS One; 2013; 8(12):e84928. PubMed ID: 24376854
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deregulated miRNAs Contribute to Silencing of B-Cell Specific Transcription Factors and Activation of NF-κB in Classical Hodgkin Lymphoma.
    Paczkowska J; Janiszewska J; Ustaszewski A; Bein J; Skalski M; Dzikiewicz-Krawczyk A; Rozwadowska N; Hansmann ML; Hartmann S; Giefing M
    Cancers (Basel); 2021 Jun; 13(13):. PubMed ID: 34201504
    [TBL] [Abstract][Full Text] [Related]  

  • 8. AP1-dependent galectin-1 expression delineates classical hodgkin and anaplastic large cell lymphomas from other lymphoid malignancies with shared molecular features.
    Rodig SJ; Ouyang J; Juszczynski P; Currie T; Law K; Neuberg DS; Rabinovich GA; Shipp MA; Kutok JL
    Clin Cancer Res; 2008 Jun; 14(11):3338-44. PubMed ID: 18519761
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA High Throughput Loss-of-Function Screening Reveals an Oncogenic Role for miR-21-5p in Hodgkin Lymphoma.
    Yuan Y; Niu F; Nolte IM; Koerts J; de Jong D; Rutgers B; Osinga J; Azkanaz M; Terpstra M; Bystrykh L; Diepstra A; Visser L; Dzikiewicz-Krawczyk A; Kok K; Kluiver J; van den Berg A
    Cell Physiol Biochem; 2018; 49(1):144-159. PubMed ID: 30184526
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pinpointing Functionally Relevant miRNAs in Classical Hodgkin Lymphoma Pathogenesis.
    Pan Y; Cengiz R; Kluiver J; Diepstra A; Van den Berg A
    Cancers (Basel); 2024 Mar; 16(6):. PubMed ID: 38539461
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-mediated down-regulation of PRDM1/Blimp-1 in Hodgkin/Reed-Sternberg cells: a potential pathogenetic lesion in Hodgkin lymphomas.
    Nie K; Gomez M; Landgraf P; Garcia JF; Liu Y; Tan LH; Chadburn A; Tuschl T; Knowles DM; Tam W
    Am J Pathol; 2008 Jul; 173(1):242-52. PubMed ID: 18583325
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Classical Hodgkin lymphoma is characterized by high constitutive expression of activating transcription factor 3 (ATF3), which promotes viability of Hodgkin/Reed-Sternberg cells.
    Janz M; Hummel M; Truss M; Wollert-Wulf B; Mathas S; Jöhrens K; Hagemeier C; Bommert K; Stein H; Dörken B; Bargou RC
    Blood; 2006 Mar; 107(6):2536-9. PubMed ID: 16263788
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of genomic imbalances in microdissected Hodgkin and Reed-Sternberg cells of classical Hodgkin's lymphoma by array-based comparative genomic hybridization.
    Hartmann S; Martin-Subero JI; Gesk S; Hüsken J; Giefing M; Nagel I; Riemke J; Chott A; Klapper W; Parrens M; Merlio JP; Küppers R; Bräuninger A; Siebert R; Hansmann ML
    Haematologica; 2008 Sep; 93(9):1318-26. PubMed ID: 18641027
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gene expression profiling of microdissected Hodgkin Reed-Sternberg cells correlates with treatment outcome in classical Hodgkin lymphoma.
    Steidl C; Diepstra A; Lee T; Chan FC; Farinha P; Tan K; Telenius A; Barclay L; Shah SP; Connors JM; van den Berg A; Gascoyne RD
    Blood; 2012 Oct; 120(17):3530-40. PubMed ID: 22955918
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Profiling of Hodgkin's lymphoma cell line L1236 and germinal center B cells: identification of Hodgkin's lymphoma-specific genes.
    Schwering I; Bräuninger A; Distler V; Jesdinsky J; Diehl V; Hansmann ML; Rajewsky K; Küppers R
    Mol Med; 2003; 9(3-4):85-95. PubMed ID: 12865944
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FOXO1 is a tumor suppressor in classical Hodgkin lymphoma.
    Xie L; Ushmorov A; Leithäuser F; Guan H; Steidl C; Färbinger J; Pelzer C; Vogel MJ; Maier HJ; Gascoyne RD; Möller P; Wirth T
    Blood; 2012 Apr; 119(15):3503-11. PubMed ID: 22343918
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD99 triggers upregulation of miR-9-modulated PRDM1/BLIMP1 in Hodgkin/Reed-Sternberg cells and induces redifferentiation.
    Huang X; Zhou X; Wang Z; Li F; Liu F; Zhong L; Li X; Han X; Wu Z; Chen S; Zhao T
    Int J Cancer; 2012 Aug; 131(4):E382-94. PubMed ID: 22020966
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Small and big Hodgkin-Reed-Sternberg cells of Hodgkin lymphoma cell lines L-428 and L-1236 lack consistent differences in gene expression profiles and are capable to reconstitute each other.
    Rengstl B; Kim S; Döring C; Weiser C; Bein J; Bankov K; Herling M; Newrzela S; Hansmann ML; Hartmann S
    PLoS One; 2017; 12(5):e0177378. PubMed ID: 28505189
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Signaling pathways and immune evasion mechanisms in classical Hodgkin lymphoma.
    Liu WR; Shipp MA
    Blood; 2017 Nov; 130(21):2265-2270. PubMed ID: 29167175
    [TBL] [Abstract][Full Text] [Related]  

  • 20. miR-24-3p Is Overexpressed in Hodgkin Lymphoma and Protects Hodgkin and Reed-Sternberg Cells from Apoptosis.
    Yuan Y; Kluiver J; Koerts J; de Jong D; Rutgers B; Abdul Razak FR; Terpstra M; Plaat BE; Nolte IM; Diepstra A; Visser L; Kok K; van den Berg A
    Am J Pathol; 2017 Jun; 187(6):1343-1355. PubMed ID: 28432871
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.